| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/27/2000 | CA2347849A1 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/27/2000 | CA2347836A1 Proliferation and apoptosis related proteins |
| 04/27/2000 | CA2347706A1 Utilization of an antifungal protein from streptomyces tendae against plant pathogenic fungi |
| 04/27/2000 | CA2347654A1 Human rna binding proteins |
| 04/27/2000 | CA2347450A1 P53 binding areas |
| 04/27/2000 | CA2347409A1 Human proteins stam2a and stam2b and cdnas encoding these molecules |
| 04/27/2000 | CA2347136A1 Neovascular-specific peptides |
| 04/27/2000 | CA2347085A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347081A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 04/27/2000 | CA2347080A1 Tnfr related gene 12 |
| 04/27/2000 | CA2347062A1 Multiple domain glycoprotein hormones and methods of using |
| 04/27/2000 | CA2346969A1 Stable concentrated insulin preparations for pulmonary delivery |
| 04/27/2000 | CA2346942A1 Camel, an alternative translation product of the tumour antigen lage-1 |
| 04/27/2000 | CA2346866A1 Combination therapy with vip antagonist |
| 04/27/2000 | CA2346798A1 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | CA2346264A1 Glypicans for the detection and treatment of human carcinoma |
| 04/27/2000 | CA2345382A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | CA2344605A1 G-protein coupled receptors |
| 04/27/2000 | CA2343974A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | CA2343917A1 Materials and methods involving conditional retention domains |
| 04/27/2000 | CA2343094A1 Interferon-beta fusion proteins and uses |
| 04/26/2000 | EP0995802A2 Method for the delivery of nucleic acids to cells in vitro or ex vivo |
| 04/26/2000 | EP0995799A2 Coccidiosis vaccines |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 04/26/2000 | EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 04/26/2000 | EP0995760A1 Synthetic peptides for the detection of trimethylamine (TMA) and their detection method and device |
| 04/26/2000 | EP0995759A1 Angiopoietin related gene sequence scarface 2 |
| 04/26/2000 | EP0995445A2 Ligand-mediated immunofunctional hormone binding protein assay method |
| 04/26/2000 | EP0995121A1 C-peptide specific assay procedure |
| 04/26/2000 | EP0995120A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
| 04/26/2000 | EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease |
| 04/26/2000 | EP0994956A1 Male tissue-preferred regulatory region and method of using same |
| 04/26/2000 | EP0994955A1 Increased production of secreted proteins by recombinant yeast cells |
| 04/26/2000 | EP0994953A1 Expression system for production of therapeutic proteins |
| 04/26/2000 | EP0994951A1 Polynucleotides and their use for detecting resistance to streptogramin a or to streptogramin b and related compounds |
| 04/26/2000 | EP0994949A1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/26/2000 | EP0994948A1 TGF$g(b) RII RECEPTOR NUCLEIC SEQUENCE, CODED PEPTIDE, AND USES |
| 04/26/2000 | EP0994947A1 Mu-1, member of the cytokine receptor family |
| 04/26/2000 | EP0994946A1 Coding sequence haplotypes of the human brca2 gene |
| 04/26/2000 | EP0994945A2 Smad-interacting polypeptides and their use |
| 04/26/2000 | EP0994944A1 Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated |
| 04/26/2000 | EP0994904A2 AMINO ACID SEQUENCES FOR THERAPEUTICAL AND PROPHYLACTIC APPLICATIONS TO DISEASES DUE TO $i(CLOSTRIDIUM DIFFICILE) TOXINS |
| 04/26/2000 | EP0994903A1 Methods and compositions for galactosylated glycoproteins |
| 04/26/2000 | EP0994902A1 Cyclic crf antagonist peptides |
| 04/26/2000 | EP0994901A1 Method for extracting, identifying, using active principles of marine mollusque shells |
| 04/26/2000 | EP0994900A1 Semaphorin receptors |
| 04/26/2000 | EP0994899A2 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN ENDODERM |
| 04/26/2000 | EP0994898A1 Integrin binding peptide and use thereof |
| 04/26/2000 | EP0994728A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0994722A1 Method of removing endotoxin from vaccines |
| 04/26/2000 | EP0994700A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 04/26/2000 | EP0873417A4 Compositions for the detection of proteases in biological samples and methods of use thereof |
| 04/26/2000 | EP0832130B1 Separating polymerized from unpolymerized hemoglobin using hydroxyapatite |
| 04/26/2000 | EP0832127B1 Synthetic peptides and pharmaceutical compositions comprising them |
| 04/26/2000 | EP0771209A4 Novel peptides |
| 04/26/2000 | EP0736102B1 Method for preparing peptide products |
| 04/26/2000 | EP0684992B1 Method for obtaining an increased production of a producing celline by using a fusion protocol |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 04/26/2000 | CN1251614A New EIA test using non-dentured HIV antigen for early detection of HIV infection |
| 04/26/2000 | CN1251612A Novel compound |
| 04/26/2000 | CN1251611A USPA1 and USPA2 antigens of moraxelia catarrhalis |
| 04/26/2000 | CN1251610A Novel mouse CXC chemokine receptor |
| 04/26/2000 | CN1251593A Selection of proteins using RNA-protein fusions |
| 04/26/2000 | CN1251390A Human guanosine monophophate reductase and its coding sequence and preparation method |
| 04/26/2000 | CN1251371A Exciter for inducing allergic reaction of plant and preparation method and use thereof |
| 04/26/2000 | CN1051811C Process for spinning polypeptide fibers and products thereof |
| 04/26/2000 | CN1051769C Parathyroid hormone analogues, their production method and medicinal composition containing same |
| 04/25/2000 | US6054638 Soybean ADP ribosylation factor |
| 04/25/2000 | US6054637 Signal sequences for vacuolar sorting |
| 04/25/2000 | US6054634 Determining whether quantitative trait is heritable oligogenic trait in family of trees of genus eucalyptus by genomic mapping using random amplified polymorphic dna markers and correlating traits with classes of progeny |
| 04/25/2000 | US6054574 Plant ubiquitin promoter system |
| 04/25/2000 | US6054573 Highly infectious rubella virus clones and methods of production |
| 04/25/2000 | US6054572 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 04/25/2000 | US6054571 dft-A gene, diagnostic and therapeutic uses thereof |
| 04/25/2000 | US6054567 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 04/25/2000 | US6054566 Recombinant animal viral nucleic acids |
| 04/25/2000 | US6054565 Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2 |
| 04/25/2000 | US6054559 Interleukin-1 receptor antagonist beta (IL-1raβ) |
| 04/25/2000 | US6054558 Amino acid sequence of isolated polypeptide from gene upregulated in endothelial cells in response to shear stress; for treatment and diagnosis of atherosclerosis, hypertension, ischemia/reperfusion, restenosis, and arterial inflammation |
| 04/25/2000 | US6054557 Fluorescent peptides |
| 04/25/2000 | US6054556 Melanocortin receptor antagonists and agonists |
| 04/25/2000 | US6054438 Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin |
| 04/25/2000 | US6054436 Regulated apoptosis |
| 04/25/2000 | US6054431 Anti-gram-positive bacterial methods and materials |
| 04/25/2000 | US6054430 Substantially free of species having a molecular weight of over 40 kilodaltons; trifluoroacetyl copolymer-1 treated with hbr. |
| 04/25/2000 | US6054429 Epidural method of producing analgesia |
| 04/25/2000 | US6054321 Forming three-dimensional structure of a fluorescent protein, constructing model of other fluorescent protein using first as template, making mutants by replacing amino acid(s) within 5 angstroms of any atom of chromophore |
| 04/25/2000 | US6054320 Includes a regent which binds to effector of arachidonic acid release in biopsy sample cells and another reagent for detectably labelling binding agent; for early, accurate diagnosis |
| 04/25/2000 | US6054313 For diagnosis of persistant hyperinsulinemic hypoglycemia of infancy; for screening drugs and antidiabetic agents; for gene therapy |
| 04/25/2000 | US6054312 Receptor-mediated gene delivery using bacteriophage vectors |
| 04/25/2000 | US6054309 Ceramide glucosyltransferase |
| 04/25/2000 | US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups |
| 04/25/2000 | US6054298 Fringe proteins and pattern formation |
| 04/25/2000 | US6054296 66 kDa antigen from Borrelia |
| 04/25/2000 | US6054295 DNA molecules encoding human nuclear receptor proteins |
| 04/25/2000 | US6054294 Nucleic acid molecules encoding the neurotrophic factor NNT-1 |
| 04/25/2000 | US6054293 Polypeptide involved in chemotatic response; screening for modulator proteins involved in nerve cell migration |
| 04/25/2000 | US6054292 T-cell receptor protein |